Evaluation of the Extent of Under-Reporting of Serious Adverse Drug Reactions
- 1 January 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 27 (7), 477-487
- https://doi.org/10.2165/00002018-200427070-00004
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Toxic epidermal necrolysisThe Lancet, 1998
- Principles of Signal Detection in PharmacovigilanceDrug Safety, 1997
- Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal NecrolysisThe New England Journal of Medicine, 1995
- Severe Adverse Cutaneous Reactions to DrugsThe New England Journal of Medicine, 1994
- Cutaneous Reactions to AnticonvulsantsSeminars in Neurology, 1992
- Toxic epidermal necrolysis: A reviewJournal of the American Academy of Dermatology, 1991
- Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysisJournal of the American Academy of Dermatology, 1989
- Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patientsArchives of Dermatology, 1987
- Improved Burn Center Survival of Patients with Toxic Epidermal Necrolysis Managed without CorticosteroidsAnnals of Surgery, 1986
- Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems.BMJ, 1983